No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...

The Law Offices of Frank R. Cruz Announces Investigation of TMC the metals company Inc. (TMC) on Behalf of Investors ...

The PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial is 100% enrolled; expect to report topline data for this cohort in late Q1 2025 or Q2 ...

The investment advisor for the Fund is Motley Fool Asset Management, LLC (“MFAM”). MFAM is a wholly owned subsidiary of Motley Fool Investment Management, LLC, whose parent company, The Motley Fool ...

The Hague5, 2024 - Please click here to access all 3Q 2024 trading update related documents. EUR 336 million operating ...

(GLOBE NEWSWIRE) -- (NASDAQ: MSGM) (“Motorsport Games” or “the Company”) today reported financial results for its third ...

The suit alleges defendants issued false statements concerning ASML business and prospects, resulting in its stock trading at ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...

SunBridge Partners. Japan is a critical market for Boomi's long-term global strategy and success. This joint venture reinforces our continued commitment to ...